La presentazione è in caricamento. Aspetta per favore

La presentazione è in caricamento. Aspetta per favore

An open-label, pilot study of fludarabine, cyclophosphamide, and alemtuzumab in relapsed/refractory patients with B-cell chronic lymphocytic leukemia by.

PubblicatoOsborn Rodgers Modificato 5 anni fa

Presentazioni simili

Presentazione sul tema: "An open-label, pilot study of fludarabine, cyclophosphamide, and alemtuzumab in relapsed/refractory patients with B-cell chronic lymphocytic leukemia by."— Transcript della presentazione:

1 An open-label, pilot study of fludarabine, cyclophosphamide, and alemtuzumab in relapsed/refractory patients with B-cell chronic lymphocytic leukemia by Marco Montillo, Alessandra Tedeschi, Valeria Belsito Petrizzi, Francesca Ricci, Monica Crugnola, Mauro Spriano, Pierangelo Spedini, Fiorella Ilariucci, Lilj Uziel, Immacolata Attolico, Eleonora Vismara, Angelo De Blasio, Alfonso Zaccaria, and Enrica Morra Blood Volume 118(15): October 13, 2011 ©2011 by American Society of Hematology

2 PFS and OS of patients receiving FCC. (A) PFS in responders.
PFS and OS of patients receiving FCC. (A) PFS in responders. (B) PFS according to response (CR vs PR). (C) OS in all 43 enrolled patients. (D) OS in responders. Marco Montillo et al. Blood 2011;118: ©2011 by American Society of Hematology

Scaricare ppt "An open-label, pilot study of fludarabine, cyclophosphamide, and alemtuzumab in relapsed/refractory patients with B-cell chronic lymphocytic leukemia by."

Presentazioni simili

Definition of COPD Chronic obstructive pulmonary disease (COPD) is a disease state characterized by airflow limitation that is not fully reversible. The.

Definition of COPD Chronic obstructive pulmonary disease (COPD) is a disease state characterized by airflow limitation that is not fully reversible. The.
LE COMPLICANZE INFETTIVE NEI PAZIENTI CON LEUCEMIA LINFATICA CRONICA (LLC) LE INFEZIONI RIMANGONO UNA DELLE PRINCIPALI CAUSE DI DI MORBIDITA’ E MORTALITA’

LE COMPLICANZE INFETTIVE NEI PAZIENTI CON LEUCEMIA LINFATICA CRONICA (LLC) LE INFEZIONI RIMANGONO UNA DELLE PRINCIPALI CAUSE DI DI MORBIDITA’ E MORTALITA’
PI3Kγ Modulates the Cardiac Response to Chronic Pressure Overload by Distinct Kinase-Dependent and -Independent Effects Enrico Patrucco, Antonella Notte,

PI3Kγ Modulates the Cardiac Response to Chronic Pressure Overload by Distinct Kinase-Dependent and -Independent Effects Enrico Patrucco, Antonella Notte,
Results of the AIEOP AML 2002/01 multicenter prospective trial for the treatment of children with acute myeloid leukemia by Andrea Pession, Riccardo Masetti,

Results of the AIEOP AML 2002/01 multicenter prospective trial for the treatment of children with acute myeloid leukemia by Andrea Pession, Riccardo Masetti,
Studi con Abraxane in combinazione con schedula settimanale: dati di efficacia e tollerabilità

Studi con Abraxane in combinazione con schedula settimanale: dati di efficacia e tollerabilità
Increased BMI correlates with higher risk of disease relapse and differentiation syndrome in patients with acute promyelocytic leukemia treated with the.

Increased BMI correlates with higher risk of disease relapse and differentiation syndrome in patients with acute promyelocytic leukemia treated with the.
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation by Mauro Di Ianni, Franca Falzetti, Alessandra Carotti, Adelmo.

Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation by Mauro Di Ianni, Franca Falzetti, Alessandra Carotti, Adelmo.
Genome Search in Celiac Disease Luigi Greco, Gino Corazza, Marie-Claude Babron, Fabienne Clot, Marie-Claude Fulchignoni-Lataud, Selvaggia Percopo, Patrizia.

Genome Search in Celiac Disease Luigi Greco, Gino Corazza, Marie-Claude Babron, Fabienne Clot, Marie-Claude Fulchignoni-Lataud, Selvaggia Percopo, Patrizia.
Carfilzomib, cyclophosphamide, and dexamethasone in patients with newly diagnosed multiple myeloma: a multicenter, phase 2 study by Sara Bringhen, Maria.

Carfilzomib, cyclophosphamide, and dexamethasone in patients with newly diagnosed multiple myeloma: a multicenter, phase 2 study by Sara Bringhen, Maria.
Efficacy and safety of once-weekly bortezomib in multiple myeloma patients by Sara Bringhen, Alessandra Larocca, Davide Rossi, Maide Cavalli, Mariella.

Efficacy and safety of once-weekly bortezomib in multiple myeloma patients by Sara Bringhen, Alessandra Larocca, Davide Rossi, Maide Cavalli, Mariella.
Additional chromosomal abnormalities in Philadelphia- positive clone: adverse prognostic influence on frontline imatinib therapy: a GIMEMA Working Party.

Additional chromosomal abnormalities in Philadelphia- positive clone: adverse prognostic influence on frontline imatinib therapy: a GIMEMA Working Party.
Identification of a New Locus for Medullary Cystic Disease, on Chromosome 16p12 Francesco Scolari, Daniela Puzzer, Antonio Amoroso, Gianluca Caridi, Gian.

Identification of a New Locus for Medullary Cystic Disease, on Chromosome 16p12 Francesco Scolari, Daniela Puzzer, Antonio Amoroso, Gianluca Caridi, Gian.
Deferiprone Versus Deferoxamine in Thalassemia Intermedia: Results from 5-Year Long-Term Italian Multi- Center Randomized Clinical Trial by Angela Vitrano,

Deferiprone Versus Deferoxamine in Thalassemia Intermedia: Results from 5-Year Long-Term Italian Multi- Center Randomized Clinical Trial by Angela Vitrano,
PET/CT Is a Useful Tool For Both Refining The Definition Of Complete Response (CR) In Multiple Myeloma (MM) and Detecting Otherwise Unrevealed Progression.

PET/CT Is a Useful Tool For Both Refining The Definition Of Complete Response (CR) In Multiple Myeloma (MM) and Detecting Otherwise Unrevealed Progression.
Randomized Trial of Busulfan with Cyclophosphamide Versus Busulfan with Fludarabine As Preparative Regimen to Allogeneic Hematopoietic Stem Cell Transplantation.

Randomized Trial of Busulfan with Cyclophosphamide Versus Busulfan with Fludarabine As Preparative Regimen to Allogeneic Hematopoietic Stem Cell Transplantation.
Incidence and Outcome of Invasive Fungal Diseases after Allogeneic Stem Cell Transplantation: A Prospective Study of the Gruppo Italiano Trapianto Midollo.

Incidence and Outcome of Invasive Fungal Diseases after Allogeneic Stem Cell Transplantation: A Prospective Study of the Gruppo Italiano Trapianto Midollo.
Che-1 phosphorylation by ATM/ATR and Chk2 kinases activates p53 transcription and the G2/M checkpoint Tiziana Bruno, Francesca De Nicola, Simona Iezzi,

Che-1 phosphorylation by ATM/ATR and Chk2 kinases activates p53 transcription and the G2/M checkpoint Tiziana Bruno, Francesca De Nicola, Simona Iezzi,
Long-Term Outcome to First-Line Imatinib according to 2013 European LeukemiaNet Response Criteria: a GIMEMA CML WP Analysis by Fausto Castagnetti, Gabriele.

Long-Term Outcome to First-Line Imatinib according to 2013 European LeukemiaNet Response Criteria: a GIMEMA CML WP Analysis by Fausto Castagnetti, Gabriele.
UP-TO-DATE SULL’ISCHEMIA CRITICA Influenza dei fattori di rischio Andrea Semplicini Medicina Interna 1 - Ospedale di Venezia Azienda ULSS 12 Veneziana.

UP-TO-DATE SULL’ISCHEMIA CRITICA Influenza dei fattori di rischio Andrea Semplicini Medicina Interna 1 - Ospedale di Venezia Azienda ULSS 12 Veneziana.
Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasia by Luca Malcovati, Elli Papaemmanuil, Ilaria Ambaglio,

Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasia by Luca Malcovati, Elli Papaemmanuil, Ilaria Ambaglio,

Presentazioni simili

Annunci Google